Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Cellular components in Cutibacterium acnes and pilosebaceous unit cells refers to the complex biological environment involved in the pathogenesis of acne vulgaris. This system includes the anaerobic bacterium Cutibacterium acnes and the host's pilosebaceous unit, which consists of the hair follicle and its associated sebaceous gland (StatPearls, 2023). C. acnes contributes to disease by secreting proinflammatory mediators and enzymes, such as lipases, which hydrolyze sebum triglycerides into irritating free fatty acids. It also triggers innate immune responses via Toll-like receptors (TLR2 and TLR4) on keratinocytes and sebocytes (PubMed, PMID: 28274357). The host components involve androgen-driven sebum production and hyperkeratinization of the follicular infundibulum, leading to ductal obstruction. Therapeutic agents targeting these components include antibiotics like clindamycin, which inhibit bacterial growth, and retinoids like isotretinoin, which reduce sebum production and normalize cell turnover (NIH, 2023). Because this entry encompasses multiple distinct bacterial and human cellular structures and pathways, it is classified as a composite system rather than a single molecular target.
Drugs targeting these components act through various mechanisms: antibiotics (e.g., clindamycin) inhibit bacterial protein synthesis; benzoyl peroxide releases reactive oxygen species to kill bacteria; retinoids (e.g., isotretinoin) normalize keratinization and reduce sebum production; and salicylic acid acts as a keratolytic agent.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular components in Cutibacterium acnes and pilosebaceous unit cells.